Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

KYG6925R1285
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG01PH1D8K8
BYAH
Park Ha Biological Technology Co., Ltd.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: -
NAME
Park Ha Biological Technology Co., Ltd.
ISIN
KYG6925R1285
TICKER
BYAH
MIC
XNAS
REUTERS
BYAH.OQ
BLOOMBERG
BYAH US
Mo., 24.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
So., 23.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Sa., 22.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 21.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 21, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline....
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 21.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadl...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 20.08.2026       Park Ha Biological
KYG6925R1285

A securities class action traces a seven-month sequence from Park Ha Biological Technology Co., Ltd.'s December 2024 public debut at $4.00 per share to its July 2025 surge above $41.49, followed by a 93% single-session collapse to $2.99 on July 8, 2025, which erased more than $1 billion in market value without any company announcement.NEW YORK, Au...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 20.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 20, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. ("Park Ha" or the "Company") (NASDAQ: BYAH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who in...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 20.08.2026       Park Ha Biological
KYG6925R1285

SAN DIEGO, Aug. 19, 2026 /PRNewswire/ -- Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities between December 27, 2024 and July 8, 2025 (the "Class Period"). The Company traded under t...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Park Ha Biological
KYG6925R1285

A securities class action traces a seven-month sequence from Park Ha Biological Technology Co., Ltd.'s December 2024 public debut at $4.00 per share to its July 2025 surge above $41.49, followed by a 93% single-session collapse to $2.99 on July 8, 2025, which erased more than $1 billion in market value without any company announcement.NEW YORK, Au...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 18.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH). Shareholders who purchased shares of BYAH during the class period listed are encouraged to contact the firm regarding poss...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Di., 18.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline....
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Di., 18.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Sa., 15.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadl...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 14.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadl...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Park Ha Biological
KYG6925R1285

Sections 11 and 12 of the Securities Act are at the center of allegations that Park Ha's December 2024 registration statement omitted that its 1,200,000-share, sub-5% public float was structured to enable a pump-and-dump scheme that ended in a 93% single-session collapse.NEW YORK, Aug. 13, 2026 /PRNewswire/ -- SueWallSt announces that a securities...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. ("Park Ha" or the "Company") (NASDAQ: BYAH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who in...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 12.08.2026       Park Ha Biological
KYG6925R1285

Three Park Ha Biological Technology Co., Ltd. insiders who signed the December 2024 registration statement are named as individual defendants, and the lawsuit contends their control over BYAH's disclosures left shareholders exposed when the stock collapsed 93% in one session.NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 12.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 12.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Di., 11.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH). Shareholders who purchased shares of BYAH during the class period listed are encouraged to contact the firm regarding poss...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mo., 10.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 10, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and certain of its officers.This lawsuit seeks to recover damages against Defendants fo...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
So., 09.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff d...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Sa., 08.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"). A class action...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 07.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"). A class action...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 07.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 7, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and certain of its officers.This lawsuit seeks to recover damages against Defendants for...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Fr., 07.08.2026       Park Ha Biological
KYG6925R1285

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 06.08.2026       Park Ha Biological
KYG6925R1285

San Diego, California--(Newsfile Corp. - August 6, 2026) - Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities between December 27, 2024 and July 8, 2025 (the "Class Period"). The Compa...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 06.08.2026       Park Ha Biological
KYG6925R1285

BYAH allegedly structured its IPO with a public float of just 1,200,000 shares, representing less than 5% of the company, a structure the lawsuit contends enabled coordinated price manipulation before BYAH shares collapsed 93% in one session.NEW YORK, Aug. 6, 2026 /PRNewswire/ -- SueWallSt alerts investors in Park Ha Biological Technology Co., Ltd...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Do., 06.08.2026       Park Ha Biological
KYG6925R1285

Levi & Korsinsky, LLP reminds purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities of a pending securities class action on behalf of shareholders who acquired securities between December 27, 2024 and July 8, 2025. See if you could be eligible to recover. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsk...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 05.08.2026       Park Ha Biological
KYG6925R1285

New York, New York--(Newsfile Corp. - August 5, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and certain of its officers.This lawsuit seeks to recover damages against Defendants for...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink
Mi., 05.08.2026       Park Ha Biological
KYG6925R1285

BYAH CFO Xiaoyan Zhu since 2016 signed the December 2024 registration statement that the lawsuit contends omitted the promotional scheme behind BYAH's 93% stock collapse.NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) that a securities class action has be...
Zur Nachricht
Park Ha Biological
Charts & Research Termsheets Terminal
Permalink